TOPLINEDanish pharmaceutical giant Novo Nordisk will boost supplies of its wildly popular obesity drug Wegovy in the United States this year, mitigating—but likely not ending—shortages as it reports huge profits but struggles to meet growing demand while expanding into new markets.KEY FACTSNovo Nordisk “started gradually increasing” supplies of lower doses of Wegovy in January, the […]
